Altre lingue HilleVax, Inc.

Azioni

HLVX

US43157M1027

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 25/06/2024			Variaz. 5gg	Var. 1 gen.
13,07 ^USD	-2,68%		+2,11%	-18,57%

24/05	Recursion nomina il CEO di HilleVax Robert Hershberg come nuovo presidente del Consiglio di Amministrazione	MT
22/05	Un insider di Hillevax ha venduto azioni per un valore di 266.291 dollari, secondo un recente deposito SEC	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Recursion Names HilleVax CEO Robert Hershberg as New Board Chair	24/05
Hillevax Insider Sold Shares Worth $266,291, According to a Recent SEC Filing	22/05
HilleVax : Corporate Presentation	20/05
HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress	09/05
Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing	05/04
HilleVax Insider Sold Shares Worth $985,536,428, According to a Recent SEC Filing	21/03
HilleVax Proposes $500 Million Offering of Equity, Debt Securities in Shelf Registration	20/03
HilleVax Q4 Net Loss Widens; Shares Extend Decline After Hours	20/03
HilleVax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
HilleVax, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/03
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress	20/03
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference	05/02
HilleVax Names New Chief Operating Officer	18/01
HilleVax Taps Sean McLoughlin as Chief Operating Officer	18/01
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer	18/01
HilleVax, Inc. Announces Executive Changes	18/01
Kanghua Biological Products Licenses Norovirus Vaccine to HilleVax	09/01
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China	08/01
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China	08/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue HilleVax, Inc.

Azioni

HLVX

US43157M1027

Altre lingue

Filtri